PYC Therapeutics Requests Trading Halt for Capital Raising
Key points
- PYC Therapeutics requests trading halt pending announcement on capital raising
- Entitlement offer and institutional placement to be undertaken
- Trading halt to remain until announcement on institutional offer completion or 4 Feb 2026
Full summary
PYC Therapeutics Limited (ASX: PYC) has requested a trading halt on its securities, pending the release of an announcement by the company. The trading halt has been requested in connection with a capital raising to be undertaken by way of a pro rata accelerated non-renounceable entitlement offer and institutional placement. PYC has requested that the trading halt remain in place until the earlier of an announcement being made about the completion of the institutional component of the entitlement offer and placement, or the commencement of trading on Wednesday, 4 February 2026. The company is not aware of any reason why the trading halt should not be granted or any other information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.